ARGX argenx SE
Healthcare$808.43+0.24%ClosedMarket Cap: $50.03B
As of 2026-05-26
Valuation
P/E (TTM)
22.96
PEG
0.02
P/B
6.89
P/S
15.05
EV/EBITDA
49.08
DCF Value
$-9,688.56
FCF Yield
1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
89.0%
Operating Margin
25.6%
Net Margin
33.4%
ROE
16.8%
ROA
13.0%
ROIC
11.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $2.41B | 88.8% | $658.6M | $874.9M | $— | — |
| FY null | $4.15B | 89.1% | $1.05B | $1.29B | $— | — |
| Q2 null | $1.75B | 88.5% | $311.7M | $418.1M | $— | — |
| Q1 null | $790.7M | 89.8% | $141.2M | $169.5M | $— | — |
| Q4 null | $1.35B | 50.6% | $117.2M | $865.6M | $— | — |
| FY null | $2.19B | 89.6% | $-21.7M | $833.0M | $— | — |
| Q3 null | $573.2M | 89.7% | $14.2M | $91.4M | $— | — |
| Q2 null | $901.9M | 142.1% | $-138.9M | $-32.5M | $— | — |
| Q1 null | $401.0M | 89.2% | $-93.4M | $-61.6M | $— | — |
| Q4 null | $757.7M | 24.3% | $-219.2M | $-155.6M | $— | — |
| FY null | $1.23B | 90.4% | $-425.0M | $-295.1M | $— | — |
| Q3 2023 | $329.8M | 89.1% | $-80.6M | $-72.6M | $-1.25 | — |